Giuseppe Pierpaolo Merola

Dr. Giuseppe Pierpaolo Merola

King's College London, London, City of London, UK
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2024 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
AHAdam Hunt
Adam Hunt
GMGiuseppe Pierpaolo Merola
Giuseppe Pierpaolo Merola
TCTom Carpenter
Tom Carpenter
AJAdrian V. Jaeggi
Adrian V. Jaeggi
Addiction poses significant social, health, and criminal issues. Its moderate heritability and early-life impact, affecting reproductive success, poses an evolutionary paradox: why are humans predisposed to addictive behaviours? This paper reviews biological and psychological mechanisms of substance and behavioural addictions, exploring evolutionary explanations for the origin and function of relevant systems. Ancestrally, addiction-related systems promoted fitness through reward-seeking, and possibly self-medication. Today, psychoactive substances disrupt these systems, leading individuals to neglect essential life goals for immediate satisfaction. Behavioural addictions (e.g. video games, social media) often emulate ancestrally beneficial behaviours, making them appealing yet often irrelevant to contemporary success. Evolutionary insights have implications for how addiction is criminalised and stigmatised, propose novel avenues for interventions, anticipate new sources of addiction from emerging technologies such as AI. The emerging potential of glucagon-like peptide 1 (GLP-1) agonists targeting obesity suggest the satiation system may be a natural counter to overactivation of the reward system.

23 June 2023 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Open access
Livio TarchiLivio Tarchi
Livio Tarchi
GMGiuseppe Pierpaolo Merola
Giuseppe Pierpaolo Merola
OBOttone Baccaredda‐Boy
Ottone Baccaredda‐Boy
FAFrancesca Arganini
Francesca Arganini
Emanuele CassioliEmanuele Cassioli
Emanuele Cassioli
GCGiovanni Castellini
Giovanni Castellini
Purpose: Adverse effects of selective serotonin reuptake inhibitors (SSRIs) on sexual function have been an important area of research for many years. However, the duration of SSRI‐associated sexual adverse effects, and their possible persistence after treatment discontinuation, is still uncertain. The aims of the current systematic review were first to identify existing evidence of sexual dysfunction following SSRI discontinuation, and to provide an account of reported symptoms and proposed treatment options; and second, to establish whether current literature allows accurate estimates of the prevalence of such sexual dysfunction.Methods: A systematic review was conducted on PubMed, Embase, and Google Scholar; papers with clinical data regarding patients with persistent sexual dysfunction after SSRI treatment suspension were included.Results: Overall, two retrospective interventional studies, six observational studies and 11 case reports were judged eligible for inclusion. It was not possible to determine reliable estimates of prevalence. Similarly, a cause‐effect relationship between SSRI exposure and persistent sexual impairment could not be ascertained. Nonetheless, the potential for continued sexual disturbances despite discontinuation could not be entirely ruled out.Conclusions: There is a need to investigate a possible dose–response relationship between SSRI exposure and persistent sexual adverse effects. Treatment options for persistent dysfunctions remain limited, but novel therapeutic approaches may be required in order to address an otherwise neglected need for sexual well‐being.

10 August 2024 in Psychiatry Research
Verified
Journal Article
Open access
CDCristiano Dani
Cristiano Dani
Livio TarchiLivio Tarchi
Livio Tarchi
Emanuele CassioliEmanuele Cassioli
Emanuele Cassioli
EREleonora Rossi
Eleonora Rossi
GMGiuseppe Pierpaolo Merola
Giuseppe Pierpaolo Merola
GCGiovanni Castellini
Giovanni Castellini
Eating disorders (EDs) are severe mental illnesses with a multifactorial etiology and a chronic course. Among the biological factors related to pathogenesis and maintenance of EDs, inflammation acquired growing scientific interest. This study aimed to assess the inflammatory profile of EDs, focusing on anorexia nervosa, bulimia nervosa, and including for the first time binge eating disorder. A comprehensive research of existing literature identified 51 eligible studies for meta-analysis, comparing levels of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), C-reactive protein (CRP), osteoprotegerin (OPG), soluble receptor activator of nuclear factor kappa-B ligand (sRANKL), interleukin-1β (IL-1β), and interleukin-10 (IL-10) between patients with EDs and healthy controls (HCs). The systematic review explored other inflammatory biomarkers of interest, which did not meet the meta-analysis criteria. Results revealed significantly elevated levels of TNF-α, OPG, sRANKL, and IL-1β in patients with EDs compared to HCs. Additionally, the results highlighted the heterogeneity of inflammatory state among patients with EDs, emphasizing the need for further research into the association between inflammatory biomarkers and psychopathological correlates. This approach should transcend categorical diagnoses, enabling more precise subcategorizations of patients. Overall, this study contributed to the understanding of the inflammatory pathways involved in EDs, emphasizing potential implications for diagnosis, staging, and targeted interventions.

26 May 2023 in Scandinavian Journal of Psychology
Verified
Journal Article
Open access
GMGiuseppe Pierpaolo Merola
Giuseppe Pierpaolo Merola
OBOttone Baccaredda Boy
Ottone Baccaredda Boy
IFIsotta Fascina
Isotta Fascina
VPVincenzo Pecoraro
Vincenzo Pecoraro
AFAndrea Falone
Andrea Falone
VRvaldo ricca
valdo ricca
Introduction: The Aberrant Salience Inventory (ASI) is a useful tool to measure salience abnormalities among the general population. There is strong clinical and scientific evidence that salience alteration is linked to psychosis. To the present day, no meta‐analysis evaluating ASI's psychometric properties and screening potential has been published.Materials and Methods: PubMed, Google Scholar, Scopus, and Embase were searched using terms including “psychosis,” “schizophrenia,” and “Aberrant Salience Inventory.” Observational and experimental studies employing ASI on populations of non‐psychotic controls and patients with psychosis were included. ASI scores and other demographic measures (age, gender, ethnicity) were extracted as outcomes. Individual patients' data (IPD) were collected. Exploratory factor analysis (EFA) was performed on the IPD.Results: Eight articles were finally included in the meta‐analysis. ASI scores differ significantly between psychotic and non‐psychotic populations; a novel three‐factor model is proposed regarding subscales structure. Theoretical positive predictive values (PPVs) and negative predictive values (NPVs) were calculated and presented together with different cutoff points depending on preselected specific populations of interest.Discussion: PPV and NPV values reached levels adequate for ASI to be considered a viable screening tool for psychosis. The factor analysis highlights the presence of a novel subscale that was named “Unveiling experiences.” Implications regarding the meaning of the new factor structure are discussed, as well as ASI's potential as a screening tool.

4 June 2024 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
GMGiuseppe Pierpaolo Merola
Giuseppe Pierpaolo Merola
LTLivio Tarchi
Livio Tarchi
LSLuigi Francesco Saccaro
Luigi Francesco Saccaro
FDFarnaz Delavari
Farnaz Delavari
CPCamille Piguet
Camille Piguet
VRValdo Ricca
Valdo Ricca
Psychotic symptoms are among the most debilitating and challenging presentations of severe psychiatric diseases, such as schizophrenia, schizoaffective, and bipolar disorder. A pathophysiological understanding of intrinsic brain activity underlying psychosis is crucial to improve diagnosis and treatment. While a potential continuum along the psychotic spectrum has been recently described in neuroimaging studies, especially for what concerns absolute and relative amplitude of low-frequency fluctuations (ALFF and fALFF), these efforts have given heterogeneous results. A transdiagnostic meta-analysis of ALFF/fALFF in patients with psychosis compared to healthy controls is currently lacking. Therefore, in this pre-registered systematic review and meta-analysis PubMed, Scopus, and Embase were searched for articles comparing ALFF/fALFF between psychotic patients and healthy controls. A quantitative synthesis of differences in (f)ALFF between patients along the psychotic spectrum and healthy controls was performed with Seed-based d Mapping, adjusting for age, sex, duration of illness, clinical severity. All results were corrected for multiple comparisons by Family-Wise Error rates. While lower ALFF and fALFF were detected in patients with psychosis in comparison to controls, no specific finding survived correction for multiple comparisons. Lack of this correction might explain the discordant findings highlighted in previous literature. Other potential explanations include methodological issues, such as the lack of standardization in pre-processing or analytical procedures among studies. Future research on ALFF/fALFF differences for patients with psychosis should prioritize the replicability of individual studies.Systematic review registration: https://osf.io/, identifier (ycqpz).

1 August 2023 in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
Verified
Journal Article
Open access
PDF file
LTLivio Tarchi
Livio Tarchi
GMGiuseppe Pierpaolo Merola
Giuseppe Pierpaolo Merola
GSGiulia Selvi
Giulia Selvi
ECEleonora Caprara
Eleonora Caprara
VPVincenzo Pecoraro
Vincenzo Pecoraro
GCGiovanni Castellini
Giovanni Castellini
Purpose: Pregorexia is a phenomenon posited to occur in the peripartum, characterized by an attempt to counter pregnancy’s physiological changes in body shape through reduced calorie intake or increased physical activity. Methods: In this pre-registered systematic review and meta-analysis, body image dissatisfaction and eating psychopathology in the peripartum according to gestational age were formally assessed. PubMed was searched up to May 2023. Selection criteria were represented by studies on body image concerns or eating psychopathology in the peripartum (up to 1 year after delivery). The population needed to include women from the general population or among patients with a history of (or current) eating disorder. For the meta-analysis, 17 studies were included: 10 for body image dissatisfaction (2625 individuals overall), 7 for eating behaviors (2551 individuals overall). The interplay between body image and the following themes was examined in depth: the adoption of breastfeeding, peripartum depression, sociocultural influences on body image, sexual disturbances, experiencing or reporting an altered food intake. Results: Progressive dissatisfaction with body image during pregnancy by gestational age was observed, stably elevated for at least 12 months postpartum. Eating psychopathology was observed as elevated only at 12 months in the postpartum, but not during pregnancy. Discussion: The current work offers normative values of body image satisfaction and eating psychopathology in the peripartum by gestational age. The relevance of current results was discussed, in order to inform both current clinical practice and future public policies. Level of Evidence: Level I—Evidence obtained from: systematic reviews and meta-analyses.